Found 72 matching trials
Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy PHASE4 The use of sodium glucose co-transporter 2 inhibitors (SGLT2i) has been ass...
Show More Location
L2 Diabetes Centre, Queen Mary Hospital
Learn More & Join Trial
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency PHASE3 Background. Treatment with intravenous iron has been shown to improve sympt...
Show More Location
Hospital de Clínicas de Porto Alegre
Learn More & Join Trial
A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients PHASE4 This is a randomised, placebo-controlled, double-blind, parallel-group, int...
Show More Learn More & Join Trial
Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy PHASE4 The DAPA-HF trial demonstrated that dapagliflozin was able to reduce the ri...
Show More Location
Cheng Hsin General Hospital
Learn More & Join Trial
Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction PHASE1 The aim of the study is to investigate the effect of dapagliflozin or place...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes PHASE4 Dapagliflozin is a member of the sodium-glucose cotransporter-2 (SGLT2) inh...
Show More Location
University Hospital of Palermo
Learn More & Join Trial
Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes PHASE4 Patients with diabetes are at increased risk of developing heart failure (H...
Show More Location
Ninewells Hospital and Medical School
Learn More & Join Trial
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study PHASE1 gemigliptin,SGLT-2i DDI study...
Learn More & Join Trial
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy PHASE4 To assess the efficacy of treatment with sitagliptin or dapagliflozin or lo...
Show More Learn More & Join Trial
Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? PHASE4 Left ventricular hypertrophy (LVH) is common in people with type 2 diabetes...
Show More Location
Ninewells Hospital
Learn More & Join Trial